Get started
RocketTickers

Regeneron and Teva Announce Positive Topline Phase 3

Long
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)  
RocketTickers  
NASDAQ:REGN   Regeneron Pharmaceuticals, Inc.
Beyond Technical Analysis
1
0
beyondta
TEVA: Teva Pharmaceutical Industries Ltd.
2018-08-16 07:00:00
Regeneron and Teva Announce Positive Topline Phase 3 Fasinumab Results in Patients with Chronic Pain from Osteoarthritis of the Knee or Hip
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.